Randomaized clinical trial to compare Dostinex versus Quinagolide to prevention of ovarian hyperstimulation syndrome
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Cabergoline (Primary) ; Quinagolide (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Adverse reactions
- 13 Apr 2017 New trial record
- 02 Mar 2017 Recruitment status is completed.